Advances in diabetes care over the past decade haven’t translated into better patient outcomes, researchers at Massachusetts General Hospital have found, with just one in four U.S. adults with the disease meeting treatment goals between 2005 and 2016.

Making the switch from analog insulin to older types of the drug can save patients money, INSIDER reports—but it can also be dangerous.

Intensive blood pressure control resulted in fewer white matter brain lesions than standard BP control in a recent study of nearly 450 hypertensive patients, suggesting stricter hypertension management could have significant benefits for brain health.

Researchers on the International Space Station are leveraging the microgravity conditions within the ISS U.S. National Laboratory to study heart cells in ways we can’t on the ground.

People who ate the most plant-based foods in a recent Journal of the American Heart Association study were 32% less likely than their counterparts to die from heart disease later down the line.

Patients with critical limb ischemia might be better off if they opt for endovascular-first treatment over an open surgical bypass, a Circulation: Cardiovascular Quality and Outcomes study suggests.

Overall exposure to ionizing radiation for patients undergoing radiofrequency ablation of AFib is “acceptable” in most cases, according to research published in the American Journal of Cardiology—but obese patients are exposed to a higher dose than their normal-weight counterparts.

In patients with both type 2 diabetes and an elevated cardiovascular risk, metformin lowers the risk of all-cause mortality but does little to protect against CV death, MI or ischemic stroke, a new evaluation of the SAVOR-TIMI 53 trial has found.